Metastatic fibrosarcoma represents a serious advancement of a rare and aggressive soft tissue cancer that has spread beyond its original location to distant parts of the body, most commonly the lungs, bones, or other organs.
Understanding Metastatic Fibrosarcoma
When fibrosarcoma spreads from where it first started to other areas of the body, it becomes metastatic. This happens when cancer cells break away from the original tumor and travel through the bloodstream or the body’s system of vessels that carry lymph fluid. Even though the cancer may now be found in the lungs or bones, it is still called fibrosarcoma rather than lung or bone cancer, because the cells remain the same type as those in the original tumor.[1]
Fibrosarcoma is a malignant neoplasm, which means a cancerous growth composed of cells called fibroblasts. These cells normally produce collagen and help form the fibrous tissue found throughout the body. In fibrosarcoma, these cells multiply out of control and create tumors in places where they shouldn’t be or in excessive amounts. This type of cancer primarily affects the connective tissues such as tendons and ligaments, which hold the body together.[2]
The cancer is considered metastatic when it reaches stage 4, indicating it has traveled far from where it began. According to medical data, approximately 83 percent of metastatic soft tissue sarcomas, including fibrosarcoma, spread to the lungs. In roughly a quarter of cases, metastasis occurs even after the original tumor has been treated.[5]
Epidemiology
Fibrosarcoma is exceptionally rare, affecting only about one person for every two million individuals worldwide. It accounts for approximately 5 percent of all primary bone sarcomas and roughly 10 percent of soft tissue sarcoma diagnoses in adults. The rarity of this condition makes gathering comprehensive statistics challenging, but experts continue to track and study its patterns.[1][2]
The disease most commonly affects middle-aged and older adults, typically those between 30 and 60 years of age. Men appear to have a slightly higher risk than women, though the difference is not dramatic. The cancer can develop anywhere in the body but shows preference for certain locations, particularly the deep soft tissues of the arms and legs. About 45 percent of cases occur in the extremities, 38 percent involve internal organs within the abdomen, 10 percent affect the trunk, and 5 percent appear in the head and neck region.[1][10]
There are two distinct types of fibrosarcoma with very different patterns. Infantile or congenital fibrosarcoma appears at birth or shortly after and is among the most common soft tissue sarcomas in children under one year old, though it remains rare overall, affecting fewer than 5 out of every million infants. This type behaves differently from the adult form—it grows rapidly but rarely spreads to distant sites and is usually curable. Adult-type fibrosarcoma, in contrast, is far more aggressive and dangerous, with a much higher tendency to metastasize.[2][4]
In studies of adult fibrosarcoma, approximately 80 percent of cases are classified as high-grade tumors, meaning they are more aggressive and more likely to spread. About 25 percent of low-grade fibrosarcomas eventually progress to become high-grade tumors over time, increasing the risk of metastasis. More than half of all people with sclerosing epithelioid fibrosarcoma, a particularly aggressive variant, experience either local recurrence or metastatic spread of their disease.[1][5]
Causes
The exact cause of fibrosarcoma remains unclear, though researchers believe genetic mutations play a central role. Many fibrosarcomas show similar changes in their cell DNA, and these abnormal alterations cause cells to multiply rapidly and form cancerous tumors. In infantile fibrosarcoma, scientists have identified that about 90 percent of cases involve problems with the NTRK gene family, which consists of three related genes. When these genes malfunction, tumors can develop.[2][3]
Fibrosarcoma typically originates from the fascia and tendons of soft tissue, but it can also arise in bones either as a primary tumor within the medullary canal (the inner marrow space of the bone) or from the periosteum (the membrane covering the bone’s surface). Secondary fibrosarcoma of the bone can develop from preexisting conditions or damage. Prior bone injury from trauma or radiation therapy may trigger the development of bone fibrosarcoma years later.[1][3]
In elderly patients, fibrosarcoma is frequently considered the result of transformation from a preexisting benign lesion. Several conditions have been linked to the later development of fibrosarcoma, including bone infarcts where lack of blood flow causes bone cells to die, lesions associated with fibrous dysplasia, chronic osteomyelitis which is long-term bone infection, and Paget’s disease of the bone. Interestingly, when fibrous dysplasia is present in just one bone rather than many, the risk of developing fibrosarcoma appears higher. This secondary form of fibrosarcoma tends to be very aggressive and carries a much poorer outlook than primary fibrosarcoma.[2][3]
Risk Factors
Several inherited genetic conditions significantly increase the risk of developing fibrosarcoma. People with familial adenomatous polyposis, Li-Fraumeni syndrome, neurofibromatosis type 1, nevoid basal cell carcinoma syndrome, retinoblastoma, tuberous sclerosis, or Werner syndrome face higher chances of developing this cancer. Individuals with neurofibromatosis, a condition causing multiple benign nerve tumors, may have as much as a 10 percent lifetime risk of developing either a neurosarcoma or fibrosarcoma.[2][3]
Environmental exposures and medical history also contribute to risk. Previous radiation therapy directed at an area of the body can lead to fibrosarcoma development years or even decades later. Exposure to certain chemicals, particularly thorium dioxide (once used as a medical contrast agent), vinyl chloride, and arsenic, has been linked to specific types of sarcomas. These substances are established carcinogens that can trigger cancerous changes in cells.[2][7]
Chronic lymphedema, which is persistent swelling caused by lymph fluid accumulation, serves as a risk factor for a specific type called lymphangiosarcoma. People with endocrine disorders appear to face elevated risk as well. In rare instances, fibrosarcoma has been reported in association with metallic implants used for fracture fixation or joint reconstruction, though the mechanism behind this connection remains unknown and the occurrence is extremely uncommon.[2][3]
Other medical conditions associated with increased fibrosarcoma risk include bone infarction, chronic osteomyelitis, fibrous dysplasia, and Paget’s disease of the bone. Certain syndromes such as Mazebraud syndrome and McCune-Albright syndrome also appear connected to this cancer. Age itself is a factor, as fibrosarcoma is most common in middle-aged and older adults, with those over 60 years old facing poorer outcomes.[2][10]
Symptoms
Fibrosarcoma symptoms often take considerable time to appear because the tumors typically develop deep within soft tissues where they aren’t easily noticed. The most common initial sign is a painless or tender lump that can be felt under the skin, usually on the legs, arms, or trunk. This mass may grow slowly or rapidly depending on the grade and type of tumor. Because the lump often doesn’t hurt at first, people may ignore it for months before seeking medical attention.[2][7]
As the tumor enlarges, it can begin pressing on nearby nerves and blood vessels, causing additional symptoms. Pressure on nerves may produce tingling sensations often described as “pins and needles,” or more severe pain that can be sharp, aching, or burning. When tumors press against blood vessels, unusual swelling may occur in the affected area. These symptoms indicate the tumor is reaching a size where it interferes with normal body structures.[2][4]
In children with fibrosarcoma, symptoms may include a painless or tender mass in an arm, leg, or the trunk, pain or soreness caused by compressed nerves and muscles, and limping or other difficulty using legs, feet, arms, and hands. The specific symptoms depend heavily on the tumor’s size, exact location, and whether it has spread.[4]
When fibrosarcoma originates in the abdomen, it typically grows unnoticed until reaching significant size. Once large enough, it starts pushing on surrounding organs, muscles, nerves, or blood vessels, leading to pain, tenderness, and depending on its location, potentially breathing difficulties. Fibrosarcoma affecting bones can be particularly tricky to identify, as symptoms often mimic sprains or growing pains. Bone involvement may cause persistent pain in the tumor area, swelling around the bone that often doesn’t show until the tumor is quite large, difficulty moving a joint or limb, numbness in areas where the tumor presses on nerves, and weakened, easily broken bones.[2][9]
It’s important to understand that fibrosarcoma symptoms closely resemble those of many other, less serious conditions. A lump, swelling, or pain doesn’t automatically indicate cancer. Only a healthcare provider can determine whether changes are due to fibrosarcoma or a more common benign condition. However, any persistent lump or pain not preceded by recent injury warrants medical evaluation.[2][7]
Prevention
Because the exact causes of fibrosarcoma remain largely unknown, there are no proven strategies for preventing this cancer. The genetic mutations that trigger fibrosarcoma cannot currently be prevented or predicted with screening tests. However, understanding and managing risk factors may help reduce danger in some cases.[2]
For individuals undergoing radiation therapy for other cancers, healthcare providers carefully weigh the benefits against the small risk of developing radiation-induced sarcomas years later. Modern radiation techniques aim to minimize exposure to surrounding healthy tissues. People with inherited genetic syndromes that increase fibrosarcoma risk should maintain regular medical follow-ups and report any new lumps or symptoms promptly to their doctors.[2][7]
Avoiding exposure to known carcinogenic chemicals when possible represents another preventive measure. Workers in industries where vinyl chloride, arsenic, or other hazardous chemicals are present should follow safety protocols and use protective equipment. Managing chronic conditions that may predispose to fibrosarcoma, such as chronic osteomyelitis or lymphedema, through proper medical care is also advisable.[7]
Early detection remains crucial since preventing fibrosarcoma isn’t currently possible. People should be aware of changes in their bodies, particularly the development of new lumps or persistent pain without obvious cause. Seeking medical evaluation promptly when concerning symptoms appear allows for earlier diagnosis and treatment, which significantly improves outcomes even if prevention isn’t possible.[2]
Pathophysiology
Fibrosarcoma is a tumor of mesenchymal cell origin, meaning it arises from cells that form connective tissues in the body. The cancer consists of malignant fibroblasts set within a background of collagen. Fibroblasts are the cells responsible for producing the fibrous connective tissue that provides structure and support throughout the body. In healthy tissue, fibroblasts create collagen in controlled amounts where needed. In fibrosarcoma, these cells lose their normal growth controls and begin multiplying excessively.[1][3]
The cancer cells in fibrosarcoma display a characteristic “herringbone” architecture when examined under a microscope, which helps pathologists identify this particular type of sarcoma. The amount of collagen production varies between tumors and relates to their grade. Higher-grade tumors, which are more aggressive, tend to produce less collagen than lower-grade ones. This variable collagen production reflects how abnormal and dangerous the cancer cells have become.[1]
Fibrosarcoma can arise as either a primary or secondary tumor. Primary fibrosarcoma is a fibroblastic malignancy that develops without any preceding condition and produces variable amounts of collagen. When it occurs in bone, it may be central, arising within the medullary canal, or peripheral, arising from the periosteum covering the bone’s surface. Secondary fibrosarcoma develops from a preexisting lesion or following radiation therapy to an area of bone or soft tissue. Secondary fibrosarcomas tend to be more aggressive and carry worse prognoses than primary tumors.[3]
The biological behavior of fibrosarcoma varies dramatically by type. Infantile fibrosarcoma, despite growing rapidly, rarely metastasizes and generally remains localized. In contrast, adult-type fibrosarcoma is highly malignant with strong propensity to spread. The cancer can metastasize through the bloodstream or lymphatic system, with cancer cells breaking away from the primary tumor and establishing new growths in distant organs. The lungs are by far the most common site of metastasis, accounting for about 83 percent of cases where fibrosarcoma spreads, though it can also reach bones, the peritoneum lining the abdomen, and other organs.[1][5]
The grade of the tumor significantly impacts its behavior. High-grade fibrosarcomas grow aggressively and are much more likely to metastasize compared to low-grade tumors. However, even low-grade lesions can progress to high-grade sarcomas over time if not completely removed, with about one-quarter showing this dangerous transformation. This progression represents the cancer cells becoming increasingly abnormal and dangerous as additional genetic mutations accumulate.[1]
